Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2'-fucosyllactose + H2O
?
-
hydrolysis by the Fuc domain of AfcA. N423 and D766 are critical for activating an attacking water molecule and N421 is critical for maintaining the water molecule and the side-chain of E566 (a general acid) in their proper orientations
-
-
?
2'-fucosyllactose + H2O
fucose + lactose
2'-fucosyllactose + H2O
L-fucose + lactose
2'-L-fucosyllactose + H2O
L-fucose + lactose
2-fucosyllactitol + H2O
fucose + lactitol
-
-
-
-
?
2-O-alpha-L-fucopyranosyl-D-galactose + H2O
L-fucose + galactose
4-methylumbelliferyl alpha-L-fucopyranoside + H2O
4-methylumbelliferone + L-fucopyranose
4-nitrophenyl alpha-L-fucopyranoside + H2O
4-nitrophenol + L-fucopyranose
4-nitrophenyl-alpha-L-fucoside + H2O
4-nitrophenol + L-fucose
-
-
-
?
alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-D-GlcNAc + H2O
L-fucose + ?
alpha-Fuc-(1-2)-beta-Gal-(1-3)-beta-GlcNAc-(1-3)-beta-Gal-(1-4)-beta-Glc + H2O
alpha-L-fucose + beta-Gal-(1-3)-beta-GlcNAc-(1-3)-beta-Gal-(1-4)-beta-Glc
-
i.e. lacto-N-fucopentaose I
-
?
alpha-Fuc-(1-2)-beta-Gal-(1-3)-beta-GlcNAc-(1-3)-beta-Gal-(1-4-)-beta-Glc + H2O
alpha-L-fucose + beta-Gal-(1-3)-beta-GlcNAc-(1-3)-beta-Gal-(1-4)-beta-Glc
Bacillus fulminans
-
-
-
-
?
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc + H2O
L-fucose + ?
i.e. blood group antigen H pentaose type-1, weak substrate
-
-
?
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-D-Gal + H2O
L-fucose + ?
i.e. blood group antigen H-tetraose type 2
-
-
?
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-D-GlcNAc + H2O
L-fucose + ?
i.e. blood group antigen H triose type-2
-
-
?
alpha-L-Fuc-(1->2)-D-Gal + H2O
L-fucose + ?
-
-
-
-
?
alpha-L-Fuc-(1->6)-beta-D-GlcNAc + H2O
?
beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GalNAc-(1->3)-D-Gal
L-fucose + ?
i.e. Lewis a tetraose
-
-
?
beta-L-fucosyl fluoride + lactose + H2O
?
-
Hehre resynthesis-hydrolysis is catalyzed by the wild-type Fuc domain of AfcA. Conversion of the inverting alpha-glycosidase to a glycosynthase
-
-
?
biotin-PAA-alpha-L-fucose + H2O
?
-
-
-
?
blood group substance H + H2O
?
bovine submaxillary mucin + H2O
L-fucose + ?
Fucalpha(1-2)Galbeta(1-3)GlcNAcbeta(1-3)Galbeta(1-4)Glc + H2O
L-fucose + Galbeta(1-3)GlcNAcbeta(1-3)Galbeta(1-4)Glc
-
i.e. lacto-N-fucopentaose I, at 29% of the activity with 2'-fucosyllactose
-
-
?
Fucalpha(1-2)Galbeta(1-4)Glc + H2O
L-fucose + Galbeta(1-4)Glc
-
i.e. 2'-fucosyllactose
-
-
?
Galbeta(1-4)(Fucalpha(1-3))Glc + H2O
?
-
i.e. 3-fucosyllactose, at 0.85% of the activity with 2'-fucosyllactose
-
-
?
glycopeptide desialyzed porcine submaxillary mucin + H2O
?
Bacillus fulminans
-
-
-
-
?
glycoprotein + H2O
?
Bacillus fulminans
-
-
-
-
?
lacto-N-fucopentaose I
?
Bacillus fulminans
-
-
-
-
?
lacto-N-fucopentaose I + H2O
?
methyl-2-alpha-L-fucopyranosyl-beta-D-galactoside + H2O
L-fucose + methyl beta-D-galactoside
N-acetyl-propargyl alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc + H2O
L-fucose + ?
i.e. blood group antigen H-pentaose type-2 beta-N-acetyl propargyl
-
-
?
O-alpha-L-fucose-(1-2)-O-beta-D-galactose-(1-4)-D-glucose + H2O
L-fucose + lactose
porcine gastric mucin + H2O
?
-
at 33% of the activity with 2'-fucosyllactose
-
-
?
porcine gastric mucin + H2O
L-fucose + ?
-
-
-
-
?
porcine submaxillary mucin + H2O
?
Bacillus fulminans
-
-
-
-
?
submaxillary glycoprotein + H2O
L-fucose + ?
-
degradation of blood group substances
-
?
additional information
?
-
2'-fucosyllactose + H2O

fucose + lactose
Bacillus fulminans
-
-
-
-
?
2'-fucosyllactose + H2O
fucose + lactose
-
-
-
-
?
2'-fucosyllactose + H2O
fucose + lactose
-
-
-
?
2'-fucosyllactose + H2O

L-fucose + lactose
-
-
-
-
?
2'-fucosyllactose + H2O
L-fucose + lactose
-
simulation of the reaction by the combined quantum mechanical and molecular mechanical approach. Molecular dynamics simulations and free energy profiles support that the overall reaction is a stepwise mechanism
-
-
?
2'-fucosyllactose + H2O
L-fucose + lactose
-
-
-
?
2'-fucosyllactose + H2O
L-fucose + lactose
-
-
-
?
2'-fucosyllactose + H2O
L-fucose + lactose
-
-
-
?
2'-fucosyllactose + H2O
L-fucose + lactose
-
-
-
-
?
2'-fucosyllactose + H2O
L-fucose + lactose
-
-
-
-
?
2'-L-fucosyllactose + H2O

L-fucose + lactose
reaction with recombinant Fuc domain
-
-
?
2'-L-fucosyllactose + H2O
L-fucose + lactose
-
reaction with recombinant Fuc domain
-
-
?
2-O-alpha-L-fucopyranosyl-D-galactose + H2O

L-fucose + galactose
-
-
-
?
2-O-alpha-L-fucopyranosyl-D-galactose + H2O
L-fucose + galactose
-
-
-
?
4-methylumbelliferyl alpha-L-fucopyranoside + H2O

4-methylumbelliferone + L-fucopyranose
-
-
-
?
4-methylumbelliferyl alpha-L-fucopyranoside + H2O
4-methylumbelliferone + L-fucopyranose
-
-
-
?
4-nitrophenyl alpha-L-fucopyranoside + H2O

4-nitrophenol + L-fucopyranose
-
-
-
-
?
4-nitrophenyl alpha-L-fucopyranoside + H2O
4-nitrophenol + L-fucopyranose
-
-
-
-
?
alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-D-GlcNAc + H2O

L-fucose + ?
i.e. blood group antigen B-tetraose type 2, weak substrate
-
-
?
alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-D-GlcNAc + H2O
L-fucose + ?
i.e. blood group antigen B-tetraose type 2, weak substrate
-
-
?
alpha-L-Fuc-(1->6)-beta-D-GlcNAc + H2O

?
-
the enzyme also possesses alpha(1,6) specificity on small unbranched substrates
-
-
?
alpha-L-Fuc-(1->6)-beta-D-GlcNAc + H2O
?
-
the enzyme also possesses alpha(1,6) specificity on small unbranched substrates
-
-
?
blood group substance H + H2O

?
74% of the activity with 2'-fucosyllactose, reaction with recombinant Fuc domain
-
-
?
blood group substance H + H2O
?
-
74% of the activity with 2'-fucosyllactose, reaction with recombinant Fuc domain
-
-
?
bovine submaxillary mucin + H2O

L-fucose + ?
-
-
-
-
?
bovine submaxillary mucin + H2O
L-fucose + ?
-
-
-
-
?
lacto-N-fucopentaose I + H2O

?
61% of the activity with 2'-fucosyllactose, reaction with recombinant Fuc domain
-
-
?
lacto-N-fucopentaose I + H2O
?
-
61% of the activity with 2'-fucosyllactose, reaction with recombinant Fuc domain
-
-
?
methyl-2-alpha-L-fucopyranosyl-beta-D-galactoside + H2O

L-fucose + methyl beta-D-galactoside
-
-
-
?
methyl-2-alpha-L-fucopyranosyl-beta-D-galactoside + H2O
L-fucose + methyl beta-D-galactoside
-
-
-
-
?
mucin + H2O

L-fucose + ?
-
porcine and canine, submaxillary
-
?
mucin + H2O
L-fucose + ?
Bacillus fulminans
-
porcine submaxillary and glycopeptide of desialyzed mucin
-
-
?
O-alpha-L-fucose-(1-2)-O-beta-D-galactose-(1-4)-D-glucose + H2O

L-fucose + lactose
-
i.e. 2-O-alpha-L-fucosyllactose
-
?
O-alpha-L-fucose-(1-2)-O-beta-D-galactose-(1-4)-D-glucose + H2O
L-fucose + lactose
Bacillus fulminans
-
i.e. 2-O-alpha-L-fucosyllactose
-
?
O-alpha-L-fucose-(1-2)-O-beta-D-galactose-(1-4)-D-glucose + H2O
L-fucose + lactose
-
i.e. 2-O-alpha-L-fucosyllactose
-
?
additional information

?
-
-
highly specific for non-reducing terminal L-fucose residues linked to D-galactose residues by 1,2-alpha linkage
-
-
?
additional information
?
-
-
inductively produced in culture medium containing porcine gastric mucin, weakly induced by L-fucose and D-arabinose, but not by other sugars including D-glucose
-
-
?
additional information
?
-
the recombinant Fuc domain shows no activity with 3-fucosyllactose, lacto-N-fucopentaose II, lacto-N-fucopentaose V and blood group substance B
-
-
?
additional information
?
-
-
the recombinant Fuc domain shows no activity with 3-fucosyllactose, lacto-N-fucopentaose II, lacto-N-fucopentaose V and blood group substance B
-
-
?
additional information
?
-
the recombinant Fuc domain shows no activity with 3-fucosyllactose, lacto-N-fucopentaose II, lacto-N-fucopentaose V and blood group substance B
-
-
?
additional information
?
-
-
the recombinant Fuc domain shows no activity with 3-fucosyllactose, lacto-N-fucopentaose II, lacto-N-fucopentaose V and blood group substance B
-
-
?
additional information
?
-
-
not: p-nitrophenyl-alpha-L-fucoside, 2-O-, 3-O- and 4-O-alpha-L-fucopyranosylfucoses, 3-O- and 4-O-alpha-L-fucopyranosyl-D-galactoses, action on oligosaccharides and glycoproteins, not: simple methyl nitrophenyl fucosides
-
-
?
additional information
?
-
-
the enzyme does not hydrolyze other fucosyloligosaccharides like Lewisa trisaccharide, Lewisx trisaccharide, 3-fucosyl-GlcNAc, 4-fucosyl-GlcNAc, 6-fucosyl-GlcNAc or 4-nitrophenyl-alpha-L-fucoside
-
-
?
additional information
?
-
substrate specificity, overview. No activity with 3-fucosyllactose. The enzyme is also active on xyloglucan
-
-
?
additional information
?
-
-
substrate specificity, overview. No activity with 3-fucosyllactose. The enzyme is also active on xyloglucan
-
-
?
additional information
?
-
-
highly specific for non-reducing terminal L-fucose residues linked to D-galactose residues by 1,2-alpha linkage
-
-
?
additional information
?
-
not active with biotin-PAA-alpha-D-galactose
-
-
?
additional information
?
-
the alpha-L-fucosidase domain of the protein accepts both alpha1-2 and alpha1-4 linked fucosylated glycans as substrates and has high affinity for a Fuc-alpha-1,2-Gal motif
-
-
?
additional information
?
-
not active with biotin-PAA-alpha-D-galactose
-
-
?
additional information
?
-
the alpha-L-fucosidase domain of the protein accepts both alpha1-2 and alpha1-4 linked fucosylated glycans as substrates and has high affinity for a Fuc-alpha-1,2-Gal motif
-
-
?
additional information
?
-
-
the alpha(1,3) and alpha(1,4) linkages are not cleaved on 3-fucosyllactose and the Lewis A trisaccharide, respectively. The enzyme is also inactive on A antigen tetraose and alpha-L-Fuc-(1->4)-beta-D-Gal
-
-
?
additional information
?
-
-
the alpha(1,3) and alpha(1,4) linkages are not cleaved on 3-fucosyllactose and the Lewis A trisaccharide, respectively. The enzyme is also inactive on A antigen tetraose and alpha-L-Fuc-(1->4)-beta-D-Gal
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(2R,3R,4R,5R,6S)-2-(aminomethyl)-6-methylpiperidine-3,4,5-triol
-
(2R,3S,4S,5R,6S)-2-benzyl-6-methylpiperidine-3,4,5-triol
-
(2S,3R,4S,5S,6R)-2-methyl-6-(propan-2-yl)piperidine-3,4,5-triol
-
2-(1H-indol-3-yl)-N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]acetamide
-
2-cyclopentyl-2-phenyl-N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]acetamide
-
3-(1H-indol-3-yl)-N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]propanamide
-
9-oxo-N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]-9H-fluorene-1-carboxamide
-
alpha-D-Gal-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-D-GlcNAc
i.e. blood group antigen B-tetraose type 2
alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-D-GlcNAc
i.e. blood group antigen A-tetraose type 2
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc
i.e. Lewisb tetraose
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-D-Gal
i.e. blood group antigen H-tetraose type 2
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-D-GlcNAc
i.e. blood group antigen H-triose type 2
alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-D-GlcNAc
i.e. Lewisy tetraose
BaCl2
-
1 mM, 63% inhibition
beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GalNAc-(1->3)-D-Gal
i.e. Lewis a tetraose
beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-D-Glc
i.e. Lewisa hexaose
beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->3)-D-Gal
i.e. Lewisx tetraose
CaCl2
-
1 mM, 60% inhibition
Co2+
0.8fold decrease of activity at 10 mM
CoCl2
-
1 mM, 38% inhibition
CuSO4
-
1 mM, 86% inhibition
cysteine
-
1 mM, 27% inhibition
D-mannose
-
10 mM, 22% inhibition
deoxycholate
Bacillus fulminans
-
-
dithiothreitol
-
1 mM, 22% inhibition
FeSO4
-
1 mM, complete inhibition
glutathione
-
1 mM, 21% inhibition
lactose
-
10 mM, 27% inhibition
Mn2+
Bacillus fulminans
-
-
N-acetyl-propargyl alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
i.e. blood group antigen H-pentaose type-2 beta-N-acetyl propargyl
N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]-1-benzofuran-2-carboxamide
-
N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]-1H-indole-2-carboxamide
-
N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methylpiperidin-2-yl]methyl]acetamide
-
NEM
-
0.1 mM, 24% inhibition
Ni2+
1.0fold decrease of activity at 10 mM
NiSO4
-
1 mM, 59% inhibition
p-chloromercuribenzoate
-
-
p-chloromercuriphenylsulfonate
-
1 mM, 12% inhibition
p-mercuribenzoate
-
1 mM, 23% inhibition
SDS
Bacillus fulminans
-
-
ZnCl2
-
1 mM, 43% inhibition
additional information
no substantial effect on alpha-L-fucosidase activity upon the addition of 10 mM EDTA or 300 mM NaCl
-
Cu2+

-
-
Cu2+
1.0fold decrease of activity at 10 mM
deoxyfuconojirimycin

-
-
deoxyfuconojirimycin
-
complete inhibition at 0.0001 mM
EDTA

-
1 mM, 23% inhibition
EDTA
Bacillus fulminans
-
-
Hg2+

-
0.1 mM, complete inhibition
Hg2+
Bacillus fulminans
-
-
L-fucose

-
10 mM, 91% inhibition
L-fucose
-
complete inhibition at 0.25 mM
Zn2+

-
-
Zn2+
1.2fold decrease of activity at 10 mM
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,2-alpha-l-fucosidase deficiency
Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation.
1,2-alpha-l-fucosidase deficiency
Increased urinary excretion of keratan sulfate in fucosidosis.
1,2-alpha-l-fucosidase deficiency
Variability of exressivity of alpha-fucosidase deficiency.
Angiokeratoma
Evolution of the neuroimaging changes in fucosidosis type II.
Arthritis, Rheumatoid
Activity of lysosomal exoglycosidases in serum and synovial fluid in patients with chronic Lyme and rheumatoid arthritis.
beta-n-acetylhexosaminidase deficiency
Molecular heterogeneity in lysosomal storage diseases. Alpha-fucosidase and N-acetyl-beta-D-hexosaminidase deficiency variants.
Candidiasis
Enhanced enzymatic activity of Candida species responsible for oral candidiasis in renal transplant recipients.
Carcinoma
Alpha-fucosidase as a marker of genetic deletion in ovarian carcinoma.
Carcinoma, Hepatocellular
Glycosidases in normal and regenerating chicken liver, hepatoma Mc-29, Rous sarcoma, in turkey poult liver and hemocytoblastomes, provoked by the leukosis virus strain Mc-31.
Carcinoma, Hepatocellular
Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer.
Colonic Neoplasms
N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects.
Cystic Fibrosis
Acid hydrolases in sera and plasma from patients with cystic fibrosis.
Cystic Fibrosis
Cystic fibrosis: depressed alpha-fucosidase activity in cultured lymphoblasts.
Dysostoses
Evolution of the neuroimaging changes in fucosidosis type II.
Endometriosis
Glycosidases in the peritoneal fluid from infertile women with and without endometriosis.
Fabry Disease
Evolution of the neuroimaging changes in fucosidosis type II.
Fabry Disease
Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
Fucosidosis
A 5' splice site mutation in fucosidosis.
Fucosidosis
A fucosidosis patient with relative longevity and a missense mutation in exon 7 of the alpha-fucosidase gene.
Fucosidosis
alpha-L-fucosidase in cultured skin fibroblasts from normal subjects and fucosidosis patients.
Fucosidosis
Biochemical and immunological characterization of a glycosylated alpha-fucosidase from the invertebrate Unio: interaction of the enzyme with its in vivo binding partners.
Fucosidosis
Detection of carriers and prenatal diagnosis for fucosidosis in Calabria.
Fucosidosis
Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation.
Fucosidosis
Human alpha-fucosidase. Single residual enzymatic form in fucosidosis.
Fucosidosis
Increased urinary excretion of keratan sulfate in fucosidosis.
Fucosidosis
Molecular defect in processing alpha-fucosidase in fucosidosis.
Fucosidosis
Variability of exressivity of alpha-fucosidase deficiency.
Gray Platelet Syndrome
Grey platelet syndrome: studies on platelet alpha-granules, lysosomes and defective response to thrombin.
HIV Infections
Activity of lysosomal exoglycosidases in saliva of patients with HIV infection.
Infections
Evolution of the neuroimaging changes in fucosidosis type II.
Infections
Semen sialic acid surge and modulation of alpha-L-fucosidase activity: possible link to loss in reproductive capacity during trypanosomiasis.
Influenza, Human
The role of carbohydrate in determining the immunochemical properties of the hemagglutinin of influenza A virus.
Liver Cirrhosis, Alcoholic
Influence of ethanol on the human serum level of beta-hexosaminidase.
Liver Neoplasms
[Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase]
Lysosomal Storage Diseases
A 5' splice site mutation in fucosidosis.
Lysosomal Storage Diseases
Molecular heterogeneity in lysosomal storage diseases. Alpha-fucosidase and N-acetyl-beta-D-hexosaminidase deficiency variants.
Mucolipidoses
Electrophoretic analysis of glycoprotein enzymes in the sialidoses and mucolipidoses.
Mucolipidoses
[Lysosomal hydrolase activity of the plasma and leukocytes of homo- and heterozygotes with various types of I-cell disease]
Mucopolysaccharidoses
Mucopolysaccharidosis by absence of alpha-fucosidase.
Myeloproliferative Disorders
Platelet lysosomal enzymes are normal in myeloproliferative disorders.
Neoplasms
Alterations of glycosidases in benign, premalignant and malignant human lesions.
Neoplasms
Enzyme activity profiles in mouse teratocarcinomas. A quantitative ultramicroscale analysis.
Neoplasms
Serum alpha-fucosidase and hexosaminidase as biological markers in human cancer.
Neoplasms
[Combined five tumor markers in detecting primary hepatic carcinoma]
Sarcoma, Avian
Glycosidases in normal and regenerating chicken liver, hepatoma Mc-29, Rous sarcoma, in turkey poult liver and hemocytoblastomes, provoked by the leukosis virus strain Mc-31.
Seizures
Evolution of the neuroimaging changes in fucosidosis type II.
Vesicular Stomatitis
Involvement of carbohydrates in vesicular stomatitis virus-cell early interaction.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.